Пароксетин

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Пароксетин

What is Paroxetine?

Property Description
Active Ingredient Paroxetine hydrochloride
Form Tablets (Oral)
Pharmacological Class Selective Serotonin Reuptake Inhibitor (SSRI)
General Purpose Mood and emotional state stabilization
Origin Synthetic

What is Paroxetine and its Class?

Paroxetine is the International Nonproprietary Name (INN) for a synthetic antidepressant that belongs to the Selective Serotonin Reuptake Inhibitor (SSRI) class. It is a single-ingredient product, and Paroxetine is classified as a psychotropic drug. This classification aligns with its primary pharmacological mechanism as a serotonin reuptake inhibitor.

Composition and Dosage Form of Paroxetine

Paroxetine is primarily formulated for oral administration, typically as coated or uncoated tablets, but it is also available as an oral suspension in some markets. The active compound is Paroxetine hydrochloride, which is combined with solid excipients necessary for stable delivery. Within the SSRI class, Paroxetine is identified as a potent inhibitor of serotonin reuptake. Its various forms, including immediate and extended-release, offer specific delivery options for healthcare providers.

What is the General Purpose of Paroxetine?

The overall purpose of Paroxetine is to stabilize mood and help regulate emotional state by supporting the brain’s chemical balance. As an SSRI, its therapeutic goal is to increase the availability of serotonin, an essential chemical messenger. By enhancing serotonergic activity, Paroxetine helps the brain manage feelings of sadness, tension, and excessive worry, and its general function has been established in clinical use for decades.

What side effects are possible with Пароксетин?

Official Adverse Reactions and Safety Profile

Regulatory documents classify the potential risks associated with Paroxetine based on frequency and affected physiological systems. The official safety profile is defined by Frequency-Classified Adverse Reactions, System-Organ-Class (SOC) groups, Label-Documented Serious Adverse Reactions, and specific Population-Specific Safety Considerations.


Frequency Classification of Adverse Reactions

Adverse effects are categorized by their estimated incidence rate, as defined in regulatory sources:

  • Very Common (Affecting 10% of patients): Nausea, and forms of Sexual dysfunction (e.g., ejaculatory failure, decreased libido).
  • Common (Affecting 1% to 10% of patients): Sweating, Drowsiness, Insomnia, Dizziness, Tremor, Dry mouth, Diarrhea, and Constipation.
  • Rare (Affecting <0.1% of patients): Serious events such as Hyponatremia (low sodium), Seizures, and Hepatitis (liver inflammation) are officially documented.

Serious Adverse Reactions and Key Constraints

Specific serious risks are highlighted in official labeling. These include the risk of Suicidal Thoughts and Behaviors, particularly in young adults during the initial months of treatment or following dose changes, which is subject to an FDA Boxed Warning. Other rare but serious documented reactions include Serotonin Syndrome, Abnormal Bleeding events, and the risk of Angle-Closure Glaucoma.

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated due to the significantly increased risk of Serotonin Syndrome. Caution is also noted for older adults and patients with hepatic or renal impairment, who may require a lower initial dose due to increased plasma concentration.

Overdose and Emergency Response

Overdose and When to Seek Help

Immediate medical attention must be sought immediately for any suspected overdose involving Paroxetine, as required by official regulatory guidance. Contact emergency services or a Poison Control Center right away.

Documented Overdose Manifestations

Official regulatory documents detail a spectrum of clinical signs, with most overdoses of Paroxetine alone resulting in limited symptoms. Common manifestations include nausea, vomiting, dizziness, somnolence, tremor, and sinus tachycardia.

Serious Outcomes and Risks

Life-threatening complications, particularly Serotonin Syndrome, are documented risks. Serotonin Syndrome involves severe changes in mental status, autonomic instability, and neuromuscular abnormalities. Seizures and coma are also listed as severe outcomes. Regulatory documents emphasize that fatalities have primarily occurred when Paroxetine was taken in overdose with other drugs or alcohol (multi-drug ingestion).

Official Management and Constraints

Treatment in a medical setting is defined as supportive and symptomatic in the absence of a known specific antidote. Management involves ensuring a patent airway, closely monitoring cardiac and vital signs, and using gastric decontamination measures like activated charcoal if appropriate. Patients, especially the elderly, require close observation due to the potential for complications like hyponatremia.

Therapeutic Uses of Пароксетин

What Пароксетин Treats: Main Uses and Benefits

Пароксетин is applied across domains where additional symptomatic support is needed, primarily focusing on conditions characterized by acute episodes and periods of heightened symptoms. The medication is commonly used to help with major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, and post-traumatic stress disorder. It is relevant in contexts marked by increased discomfort or tension, helping to address symptom clusters that interfere with daily comfort. Patients generally find that it helps improve day-to-day comfort during symptomatic periods by providing supportive relief when symptoms interfere with routine activities.

“Пароксетин provides support that helps ease the overall symptom burden during difficult episodes.”

Quick Fact: Support for Heightened Symptoms

Quick Fact: Support for heightened symptoms (such as those involving physiological activity or functional stress) is a relevant clinical benefit, as the medication is relevant in clinical settings that involve acute or unstable symptom patterns.

Regulatory References

  1. National Library of Medicine's DailyMed service

Eligibility and Restrictions for Use

Regulatory documents establish strict criteria regarding who is eligible to use Paroxetine.

Contraindicated Populations

Use is absolutely contraindicated in patients with a known hypersensitivity to the drug or any of its components. It is also prohibited for patients currently taking, or who have recently stopped (within the last 14 days), a Monoamine Oxidase Inhibitor (MAOI). Co-administration with Pimozide or Thioridazine is also contraindicated due to increased risk of serious adverse effects.


Age and Organ Function Restrictions

Population Group Official Regulatory Status
Children and Adolescents (Under 18) Not approved/Not Indicated for most disorders, citing lack of established efficacy and concerns over increased risk of suicidal ideation.
Older Adults (Geriatric) Use is permitted, but requires a reduced initial dosage.
Severe Renal/Hepatic Impairment Use is permitted, but requires a reduced initial dosage.
Pregnancy and Lactation Use requires careful benefit/risk evaluation by a healthcare provider, especially during the first trimester of pregnancy and while breastfeeding.

Conditional Use

Paroxetine must be used with caution and under close monitoring in patients with a history of mania/hypomania, seizure disorders/epilepsy, or those at risk of angle-closure glaucoma.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents establish specific combinations that are prohibited. The co-administration of Monoamine Oxidase Inhibitors (MAOIs), including Linezolid and Intravenous Methylene Blue, is contraindicated due to the officially documented risk of serotonin syndrome. A mandatory 14-day washout period is required when switching between Paroxetine and an MAOI, and vice versa.

Additionally, Thioridazine and Pimozide are contraindicated because Paroxetine is documented to elevate their plasma concentrations, increasing the official risk of QT prolongation.


Paroxetine is officially classified as a potent inhibitor of the CYP2D6 enzyme. This pharmacokinetic effect significantly increases the systemic concentration of co-administered drugs metabolized by CYP2D6 (e.g., Tamoxifen and certain antiarrhythmics), as stated in regulatory labels. Combining Paroxetine with other serotonergic agents (e.g., Triptans, Tramadol) or the herbal product St. John's Wort may lead to additive effects, increasing the risk of serotonin syndrome.

Co-administration with oral anticoagulants or NSAIDs is officially noted to increase the risk of abnormal bleeding due to pharmacodynamic effects on platelet function. Food intake is documented to slightly increase Paroxetine's maximum plasma concentration (C max). Official labels advise that alcohol should be avoided. Regulatory documents also note that Paroxetine exposure is increased in patients with severe hepatic impairment.

Mechanism of Action

How Пароксетин Works: Pharmacodynamic Mechanism

This medication primarily acts by selectively inhibiting the Serotonin Transporter ( SERT) protein located on presynaptic neuronal membranes. This action blocks the reuptake of the neurotransmitter serotonin ( 5-HT) from the synaptic cleft, leading to an elevated extracellular concentration of 5-HT. This increase initiates a cascade that alters signaling dynamics within 5-HT-dependent neural circuits.

Over several weeks, this sustained 5-HT activity triggers adaptive changes, including the gradual desensitization of inhibitory 5-HT1 A autoreceptors. This receptor remodeling allows for a sustained alteration of serotonergic signaling and promotes the activity of Brain-Derived Neurotrophic Factor ( BDNF), which is associated with changes in structural neuroplasticity.

Additionally, the molecule exhibits antagonism at secondary targets, specifically Muscarinic Cholinergic ( M1) and Histamine H1 Receptors. This engagement with secondary systems affects aspects of autonomic function and central arousal, contributing to the overall systemic physiological response profile.

Dosage and Administration Information

Official Administration and Dosage Guidelines

Paroxetine (Пароксетин) is administered orally and is available in immediate-release (IR) tablets, extended-release (CR) tablets, and an oral suspension. Both IR and CR formulations are prescribed as a single daily dose, typically taken in the morning. Immediate-release tablets are generally taken with food, while the administration context for extended-release tablets may vary by formulation.

Labeled Dosing and Adjustment

Administration Scope Standard Administration Instructions
Standard Adult Dose (IR) Starting dose is commonly 20 mg once daily, with a maximum daily dose of 50 mg (up to 60 mg for specific indications).
Titration Interval Dosage adjustments, when necessary, are made slowly in increments (e.g., 10 mg for IR) at intervals of at least one week.
Older Adults / Impairment A lower starting dose (e.g., 10 mg for IR) is required for elderly patients and those with severe renal or hepatic impairment, with a reduced maximum dose, often 40 mg/day.
Preparation/Handling Extended-release tablets must be swallowed whole and should not be chewed or crushed. Oral suspension must be shaken well before use.

Course Duration and Discontinuation

Treatment duration often extends for several months or longer. Abrupt discontinuation is strongly discouraged. When stopping the medicine, the dose must be gradually reduced (tapered) over a period of weeks or months to minimize discontinuation phenomena.

Recent Clinical Evidence

Paroxetine: Recent Clinical Evidence

Clinical research supports the use of Paroxetine, an SSRI (selective serotonin reuptake inhibitor), across several established indications. Studies focus on evaluating its profile relative to other pharmacotherapies and assessing long-term outcomes.

Efficacy in Major Depressive Disorder (MDD)

Recent randomized controlled trials (RCTs) continue to affirm Paroxetine's efficacy in treating acute and maintenance phases of MDD. Research consistently reports that patients treated with Paroxetine experience a greater reduction in HAM-D (Hamilton Rating Scale for Depression) scores compared to placebo. However, evidence suggests that the magnitude of this effect is similar to that of many other modern SSRIs, meaning no clinical superiority is broadly confirmed across the class.

Anxiety and Panic Disorders

Paroxetine remains a key pharmacological option for Panic Disorder and Social Anxiety Disorder (Social Phobia). Trials for Panic Disorder demonstrate a statistically significant reduction in the frequency and severity of panic attacks. For Social Anxiety Disorder, studies indicate Paroxetine is associated with improved social functioning and reduced fear, particularly in generalized social anxiety. The time to observed response in anxiety often requires several weeks of consistent use, with peak effects documented after 8–12 weeks of treatment.

Tolerability and Safety Profile

Contemporary research primarily examines the long-term tolerability of Paroxetine, particularly focusing on sexual dysfunction and weight changes, which are recognized side effects. Discontinuation syndrome, or withdrawal symptoms upon stopping treatment, is consistently noted in clinical literature as a specific concern for Paroxetine due to its relatively short half-life compared to some other SSRIs. Gradual tapering under medical supervision is consistently recommended to mitigate this risk.

Key Studies & References

  1. NICE Guideline: Depression in adults: recognition and management

Frequently Asked Questions (FAQ)

Common questions about Пароксетин (FAQ)


Q: How long does it take to feel the effect of Paroxetine?

To experience the full therapeutic effect, treatment often requires several weeks or a longer period of consistent use. For specific anxiety disorders, the official evidence suggests that peak effects are typically observed after 8 to 12 weeks of treatment.


Q: What sensations or feelings might be experienced at the start of taking Paroxetine?

During the first few weeks, as the drug concentration stabilizes, common side effects may appear. These documented sensations can include nausea, drowsiness, dizziness, tremor, and dry mouth. These effects are often transient, and patient reports suggest they may lessen with continued treatment.


Q: Why does Paroxetine sometimes cause drowsiness?

Drowsiness is an officially documented common side effect. Regulatory documents describe that Paroxetine has a secondary antagonistic effect on certain receptors, including the Histamine (H1) and Muscarinic Cholinergic (M1) receptors. This engagement with secondary systems is generally understood to contribute to the sedative response.


Q: Is it true that Paroxetine can cause weight gain?

Official clinical research examines weight changes as a recognized side effect associated with Paroxetine. While some studies suggest decreased appetite or weight loss is sometimes observed early in treatment, information regarding significant weight change is relevant for the healthcare provider to evaluate during treatment monitoring.


Q: How does Paroxetine differ from Fluoxetine or Sertraline?

Paroxetine is classified as a potent selective serotonin reuptake inhibitor (SSRI). Official pharmacokinetic data indicates it has a relatively short mean elimination half-life, approximately 21 hours. This short half-life, compared to some other SSRIs, is a factor that contributes to the occurrence of discontinuation symptoms if treatment is stopped abruptly.


Q: Can any specific foods reduce the effectiveness of Paroxetine?

Official regulatory documents note that taking the medication with food can slightly increase its maximum plasma concentration (Cmax). However, there is no documentation indicating that any specific foods are known to reduce the overall effectiveness of the drug.


Q: Which herbs or supplements should not be taken together with Paroxetine?

Official instructions warn about the risk of increasing serotonergic activity when Paroxetine is taken simultaneously with certain medications or the herbal product St. John’s Wort. This combination carries the risk of increasing the likelihood of serious adverse reactions.


Q: What is 'discontinuation syndrome' when stopping Paroxetine?

Discontinuation syndrome, or withdrawal phenomenon, can occur if treatment is stopped too quickly. Officially documented symptoms can include irritability, nausea, vomiting, dizziness, headache, nightmares, and paresthesias (a prickling or tingling sensation). Regulatory guidelines mandate that the dose must be gradually reduced (tapered) over a period of time to minimize this phenomenon.


Q: Are there studies confirming the long-term safety of Paroxetine?

Clinical studies and contemporary research continue to examine the long-term tolerability of the medication. This research specifically focuses on chronic side effects, such as changes in sexual function and body weight, which are officially recognized risks associated with the drug.


Q: Does Paroxetine affect liver function?

Paroxetine may cause rare serious adverse reactions, such as Hepatitis (liver inflammation). Furthermore, regulatory guidelines specify that dose adjustment is necessary for patients with severe liver impairment.


Q: If Paroxetine helps, can it be taken permanently?

Treatment duration for Paroxetine often extends for several months or longer. Official regulatory documents include indications for the maintenance phase of treating major depressive disorder. This use in maintenance supports the possibility of prolonged administration under appropriate supervision.


Q: Does Paroxetine affect concentration?

Officially documented common side effects include drowsiness and dizziness, which influence the central nervous system. These effects may impact a person’s concentration and ability to perform tasks that require focus.


Q: What is serotonin syndrome related to Paroxetine?

Serotonin syndrome is a serious, though rare, reaction associated with an excessive increase in serotonin levels, particularly when co-administered with other serotonergic agents. Documented symptoms can include fever, confusion, seizures, fast heartbeat, muscle rigidity, and involuntary muscle twitching.


Q: Why can Paroxetine cause dry mouth?

Dry mouth is an officially documented common side effect. This is associated with the drug's secondary action as an antagonist at certain receptors, specifically the Muscarinic Cholinergic (M1) receptors. This effect is a documented anticholinergic action of the medication.


Q: Why might Paroxetine be cautioned against in glaucoma?

Official instructions advise caution when using the drug in patients who are at risk of developing angle-closure glaucoma. Antidepressants can potentially trigger a glaucoma attack in individuals with untreated anatomically narrow angles in the eye.


Q: Can Paroxetine be taken with coffee?

Regulatory documents officially advise avoiding the use of alcohol during treatment with Paroxetine. However, a direct, significant interaction with caffeine or coffee is not specified within the official listing of strict or moderate drug-product interactions.


Q: How long after stopping Paroxetine is it completely eliminated from the body?

The official pharmacokinetic data indicates that the mean elimination half-life of Paroxetine is approximately 21 hours. Complete elimination of the drug from the body generally takes several half-lives. A stable concentration in the bloodstream is usually achieved after 7 to 14 days of consistent use.


Q: Is Paroxetine addictive or habit-forming?

Official regulatory documents do not classify Paroxetine as an addictive or habit-forming substance. However, when stopping the drug, gradual dose reduction (tapering) is necessary to mitigate the physical dependence that results in the discontinuation phenomenon.


Q: Can Paroxetine affect the ability to drive a car?

Since Paroxetine may cause central nervous system side effects such as drowsiness, dizziness, and impaired attention, the official safety profile advises caution regarding operating vehicles or heavy machinery, as these effects may impair performance.


Q: Can Paroxetine be taken if I have heart problems?

Official documents prohibit the co-administration of Paroxetine with other medications known to prolong the QT interval (such as Pimozide or Thioridazine) due to the risk of serious heart rhythm issues. Any general concerns about existing cardiac conditions are a factor for healthcare providers to evaluate based on the regulatory safety profile.


Q: Can Paroxetine be bought without a prescription?

No. According to the regulatory classification (Human Prescription Drug Label), Paroxetine is designated as a prescription-only medication.


Q: What should I do if I miss a dose of Paroxetine?

Official patient information contains instructions detailing how to handle a missed dose, generally advising to resume the schedule and not take a double dose if the next dose is imminent. Patients should reference their specific patient leaflet or consult a professional for clarification.


Q: How long can the side effects of Paroxetine last at the beginning of treatment?

Official clinical summaries note that many of the common adverse effects that occur during the initial phase of treatment are temporary. These effects are often transient, and patient reports suggest they may resolve as the body adjusts to the medication and reaches a stable concentration (steady state).


Q: Why do doctors prescribe Paroxetine for Obsessive-Compulsive Disorder (OCD)?

Obsessive-Compulsive Disorder (OCD) in adults is one of the officially approved and indicated uses for Paroxetine, as supported by clinical evidence.


Q: Is it true that Paroxetine can help with Post-Traumatic Stress Disorder (PTSD)?

Post-Traumatic Stress Disorder (PTSD) in adults is one of the officially approved and indicated uses for Paroxetine, as supported by clinical evidence.


Q: What are the signs that Paroxetine is not suitable for a person?

Signs that the medication may be unsuitable include the presence of strict contraindications (such as taking certain MAO inhibitors) or the emergence of serious adverse reactions. The regulatory safety profile warns about serious risks like Serotonin Syndrome or the onset of suicidal thoughts or behavior.


Q: Why is Paroxetine a prescription-only medication?

The drug is classified as a prescription-only product due to the necessity for careful medical observation (monitoring) during its use. This monitoring is mandated due to the risk of serious adverse effects, including the FDA Boxed Warning regarding suicidal thoughts and behaviors.


Q: Does Paroxetine have a 'build-up' or accumulation effect in the body?

Official pharmacokinetic data indicates that Paroxetine reaches a stable concentration in the bloodstream, known as 'steady state,' after approximately 7 to 14 days of consistent dosing. This stable level is maintained as long as the treatment continues.


Q: What happens if I accidentally take a double dose of Paroxetine?

Taking too large of a dose may result in symptoms of overdose, which are documented in the official safety materials. These serious symptoms can include fever, confusion, seizures, fast or irregular heartbeat, muscle twitching, and severe muscle stiffness.


Q: Does Paroxetine affect appetite?

Yes, according to the official adverse reactions profile, a decrease in appetite is one of the commonly observed side effects associated with the use of Paroxetine.

How should Пароксетин be stored and disposed of?

Paroxetine must be stored according to officially labeled requirements to maintain stability and prevent unintentional exposure.

Storage Category Official Requirement
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F). Brief excursions are permitted up to 30 C (86 F).
Protection Keep away from excess heat and moisture; do not store in high-humidity areas like the bathroom.
Container Must be kept in the original container and the container must be tightly closed.

All paroxetine formulations must be stored out of the sight and reach of children.

For disposal, unused or expired medication should generally not be flushed down the toilet. Instead, mix the product with an unappealing substance (like used coffee grounds or dirt), place the mixture in a sealed bag or container, and discard it in the household trash, following established regulatory guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Пароксетин found in:

A-Z Index: